1
|
Jin Y, Nishizawa T, Sugimoto N, Takakura S, Aoki M, Ishii S, Yamazaki A, Kudo R, Yumimoto K, Sato K, Okamoto H. Demonstration of aerosol profile measurement with a dual-wavelength high-spectral-resolution lidar using a scanning interferometer. Appl Opt 2022; 61:3523-3532. [PMID: 36256389 DOI: 10.1364/ao.451707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/17/2021] [Accepted: 03/22/2022] [Indexed: 06/16/2023]
Abstract
Simple dual-wavelength high-spectral-resolution lidar at 355 and 532 nm with a scanning interferometer was developed for continuous observations of aerosol profiles. Scanning the interferometer periodically over a range of one fringe at 532 nm (1.5 fringes at 355 nm) enabled recording of range-resolved interference signals at these two wavelengths. Reference signals taken from the transmitted laser were used to correct the interference phase shift due to laser frequency variation for every scan. Profiles of aerosol backscatter and extinction coefficients were retrieved from range-resolved interference data. One month of continuous measurements demonstrated the robustness of the system.
Collapse
|
2
|
Li Q, Jiang B, Guo J, Shao H, Del Priore IS, Chang Q, Kudo R, Li Z, Razavi P, Liu B, Boghossian AS, Rees MG, Ronan MM, Roth JA, Donovan KA, Palafox M, Reis-Filho JS, de Stanchina E, Fischer ES, Rosen N, Serra V, Koff A, Chodera JD, Gray NS, Chandarlapaty S. INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors. Cancer Discov 2022; 12:356-371. [PMID: 34544752 PMCID: PMC8831444 DOI: 10.1158/2159-8290.cd-20-1726] [Citation(s) in RCA: 62] [Impact Index Per Article: 31.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2020] [Revised: 07/13/2021] [Accepted: 09/15/2021] [Indexed: 01/22/2023]
Abstract
Cyclin-dependent kinases 4 and 6 (CDK4/6) represent a major therapeutic vulnerability for breast cancer. The kinases are clinically targeted via ATP competitive inhibitors (CDK4/6i); however, drug resistance commonly emerges over time. To understand CDK4/6i resistance, we surveyed over 1,300 breast cancers and identified several genetic alterations (e.g., FAT1, PTEN, or ARID1A loss) converging on upregulation of CDK6. Mechanistically, we demonstrate CDK6 causes resistance by inducing and binding CDK inhibitor INK4 proteins (e.g., p18INK4C). In vitro binding and kinase assays together with physical modeling reveal that the p18INK4C-cyclin D-CDK6 complex occludes CDK4/6i binding while only weakly suppressing ATP binding. Suppression of INK4 expression or its binding to CDK6 restores CDK4/6i sensitivity. To overcome this constraint, we developed bifunctional degraders conjugating palbociclib with E3 ligands. Two resulting lead compounds potently degraded CDK4/6, leading to substantial antitumor effects in vivo, demonstrating the promising therapeutic potential for retargeting CDK4/6 despite CDK4/6i resistance. SIGNIFICANCE: CDK4/6 kinase activation represents a common mechanism by which oncogenic signaling induces proliferation and is potentially targetable by ATP competitive inhibitors. We identify a CDK6-INK4 complex that is resilient to current-generation inhibitors and develop a new strategy for more effective inhibition of CDK4/6 kinases.This article is highlighted in the In This Issue feature, p. 275.
Collapse
Affiliation(s)
- Qing Li
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Baishan Jiang
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts
| | - Jiaye Guo
- Computational & Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Hong Shao
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Isabella S Del Priore
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Qing Chang
- Anti-Tumor Assessment, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Rei Kudo
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Zhiqiang Li
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Pedram Razavi
- Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
- Weill Cornell Medical College, New York, New York
| | - Bo Liu
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | | | - Matthew G Rees
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts
| | - Melissa M Ronan
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts
| | - Jennifer A Roth
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts
| | - Katherine A Donovan
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts
| | - Marta Palafox
- Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - Jorge S Reis-Filho
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Elisa de Stanchina
- Anti-Tumor Assessment, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Eric S Fischer
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts
| | - Neal Rosen
- Program in Molecular Pharmacology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Violeta Serra
- Vall d'Hebron Institute of Oncology, Barcelona, Spain
| | - Andrew Koff
- Program in Molecular Biology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - John D Chodera
- Computational & Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Nathanael S Gray
- Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts
- Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts
| | - Sarat Chandarlapaty
- Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.
- Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York
- Weill Cornell Medical College, New York, New York
| |
Collapse
|
3
|
Nagasaki E, Kudo R, Tamura M, Hayashi K, Uwagawa T, Kijima Y, Nogi H, Takeyama H, Suzuki M, Nishikawa M, Yano S, Kobayashi T. Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report. Breast Cancer 2021; 28:1051-1061. [PMID: 33840010 DOI: 10.1007/s12282-021-01240-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/13/2020] [Accepted: 03/13/2021] [Indexed: 02/06/2023]
Abstract
BACKGROUND Oligometastatic breast cancer (OMBC) is characterized by limited metastatic tumor numbers and sites. We have reported a 20-year overall survival (OS) rate and relapse-free rate (RFR) of 34.1% and 27.4%, respectively, in a retrospective analysis of OMBC patients treated with curative intent including a multidisciplinary approach. Metastatic breast cancer (MBC) is generally incurable; however, OMBC might be a potentially curable subset. The previous analysis included isolated locoregional recurrence (ILRR) cases, which differs from distant metastasis in treatment strategies. Therefore, in this study, we excluded ILRR cases and provided an update on clinical outcomes. We also performed a detailed subgroup analysis of OMBC patients by introducing new prognostic variables. METHODS Data of 73 OMBC patients, including 10 ILRR cases, treated in our institution between 1980 and 2010 were retrospectively analyzed. OMBC was defined as the presence of metastatic lesions in 1-2 organs, < 5 lesions per metastasized organ, and lesion diameter < 5 cm. RESULTS The median follow-up duration was 151 (range 12-350) months. Twenty-eight (44%) patients received local therapy. Excluding ILRR cases, the OS rates were 28.3% and 18.9% and RFRs were 26.7% at 20 and 25 years, respectively. In multivariate analysis, single-organ involvement and three or fewer metastatic lesions per organ were associated with a longer progression-free and relapse-free interval (RFI). CONCLUSIONS Relapse-free interval reached a plateau after 20 years at approximately 25% probability. Patients with long-term survival without disease relapse are considered cured. Curative-intent therapy should be considered for OMBC patients, especially those with low tumor volume.
Collapse
Affiliation(s)
- Eijiro Nagasaki
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan.
| | - Rei Kudo
- Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Miho Tamura
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Kazumi Hayashi
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Tadashi Uwagawa
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Yoshikazu Kijima
- Department of Radiology, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan
| | - Hiroko Nogi
- Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Hiroshi Takeyama
- Department of Surgery, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Masafumi Suzuki
- Department of Pathology, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan
| | - Masako Nishikawa
- Clinical Research Support Center, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-Ku, Tokyo, 105-8461, Japan
| | - Shingo Yano
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| | - Tadashi Kobayashi
- Division of Clinical Oncology and Hematology, The Jikei University School of Medicine, 3-25-8 Nishi-shimbashi, Minato-ku, Tokyo, Japan
| |
Collapse
|
4
|
Kawaguchi K, Manaka D, Konishi S, Ota T, Ikeda Y, Kudo R, An H, Sasaki N, Hamasu S, Nishitai R, Mori Y, Inamoto N, Shibamoto K, Ogata A, Yamaoka T, Himoto Y. P-145 CT-based texture analysis using radiomics for hepatic sinusoidal obstruction syndrome (HSOS) in colorectal cancer patients treated with oxaliplatin containing chemotherapy. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
5
|
Konishi S, Manaka D, Kawaguchi K, Ota T, Ikeda Y, Kudo R, An H, Sasaki N, Hamasu S, Nishitai R, Mori Y, Inamoto N, Shibamoto K, Ogata A, Yamaoka T, Himoto Y. SO-15 Radiomic signature for prediction of peritoneal disseminations in gastric cancer which were not detected by routine CT examinations. Ann Oncol 2020. [DOI: 10.1016/j.annonc.2020.04.030] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
6
|
Fushimi A, Kudo R, Takeyama H. Abstract P2-01-02: Do decreased breast microcalcifications after neoadjuvant chemotherapy predict pathological complete response? Cancer Res 2020. [DOI: 10.1158/1538-7445.sabcs19-p2-01-02] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Clinical response evaluation by image examination after neoadjuvant chemotherapy for breast cancer is important for determining drug response and progression. Mammography is less correlated with pathological response assessment than magnetic resonance imaging or ultrasonography particularly because mammographic calcifications can increase or decrease in response to neoadjuvant chemotherapy. A conventional theory of breast microcalcifications is that they are likely to paradoxically change with neoadjuvant chemotherapy. Traditionally, microcalcifications have been said to occur due to necrosis. If conventional theory is correct, the increase in necrotic cells would increase microcalcifications in response to neoadjuvant chemotherapy. However, decreased microcalcifications were found as a clinical response to neoadjuvant chemotherapy in many cases. To increase the diagnostic ability of mammography after neoadjuvant chemotherapy, it is important to clarify the cases in which microcalcifications can be reduced by anticancer agents. The present study clarified characteristics of breast cancer cases with decreased microcalcifications after neoadjuvant. Methods: Consecutive patients who received neoadjuvant chemotherapy for breast cancer at our hospital from January 2013 to June 2017 were retrospectively reviewed. Characteristics of cases with microcalcifications before neoadjuvant chemotherapy and those showing a reduction after were examined. Stromal tumor-infiltrating lymphocytes were evaluated in the biopsy. before neoadjuvant chemotherapy based on the protocol of the International TILs Working Group 2014. Pathological complete response was also explored in cases exhibiting a decrease in microcalcifications by neoadjuvant chemotherapy. In addition, sensitivity, specificity, and likelihood ratios were calculated for pCR assessment in patients with segmental microcalcifications, pleomorphic/linear microcalcifications, and microcalcifications without mammographic mass. Results: A total of 184 breast cancer cases, including 8 with synchronous bilateral breast cancer, received neoadjuvant chemotherapy at our hospital. Of them, 114 cases were excluded due to unavailable mammograms at our institute before or after neoadjuvant chemotherapy. Seventy breast cancer cases were included; 37 had no malignant microcalcifications before neoadjuvant chemotherapy and 33 did. Breast cancer with microcalcifications was significantly more positive for human epidermal growth factor receptor 2 than those without microcalcifications (48% versus 22%, P = 0.018). Only 6 out of 33 cases with microcalcifications before neoadjuvant chemotherapy showed a decrease after treatment. These cases tended to have high stromal tumor-infiltrating lymphocytes (50% versus 17%), segmental microcalcifications (66% versus 33%), and pleomorphic/linear microcalcifications (83% versus 37%). The sensitivity of each group, compared with total cases of microcalcifications after neoadjuvant chemotherapy, tended to increase, although no significant difference was observed (sensitivity; patients with segmental microcalcifications, 42.9%; patients with pleomorphic/linear microcalcifications, 57.1%; and patients with microcalcifications but without mass, 50.0%). Conclusion: These results suggest that neoadjuvant chemotherapy is able to decrease malignant calcifications, particularly segmental and pleomorphic/linear microcalcifications and microcalcifications with high stromal tumor-infiltrating lymphocytes. By clarifying the mechanisms of formation and disappearance of microcalcifications, a consensus can be reached on whether microcalcifications apparent by mammography are useful for evaluating response to neoadjuvant chemotherapy.
Citation Format: Atsushi Fushimi, Rei Kudo, Hiroshi Takeyama. Do decreased breast microcalcifications after neoadjuvant chemotherapy predict pathological complete response? [abstract]. In: Proceedings of the 2019 San Antonio Breast Cancer Symposium; 2019 Dec 10-14; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2020;80(4 Suppl):Abstract nr P2-01-02.
Collapse
Affiliation(s)
| | - Rei Kudo
- The Jikei University School of Medicine, Tokyo, Japan
| | | |
Collapse
|
7
|
Chaikovsky A, Bril A, Dubovik O, Fedarenka A, Goloub P, Hu Q, Lopatin A, Lapyonok T, Miatselskaya N, Torres B, Fuertes D, Peshcharankou V, Podvin T, Popovici I, Liu D, Li Z, Soupiona O, Mylonaki M, Mona L, Giunta A, Papagiannopoulos N, Perrone MR, Romano S, Balis D, Siomos N, Voudouri KA, Belegante L, Nicolae D, Ene D, Ajtai N, Stefanie H, Amiridis V, Tsekeri A, Bortoli D, Costa MJ, Mattis I, Rocadenbosch F, Rodríguez-Gomez A, Sicard M, Fernandez AJ, Molero F, Althausen D, Baars H, Rascado JLG, Ortiz-Amezcua P, Oltra JAB, Bedoya-Velásquez AE, Román R, Alados-Arboledas L, Balin Y, Kokhanenko G, Penner I, Chen B, Sverdlik L, Milinevsky G, Sugimoto N, Shimizu A, Nishizawa T, Kudo R, Sano I, Yasunari TJ, Irie H, Takemura T, Kim SW, Anh NX, Thanh PX, Pietruczuk A, Stachlewska IS, Sannino A, Wang X, Boselli A. Synergetic Observations by Ground-Based and Space Lidar Systems and Aeronet Sun-Radiometers: A Step to Advanced Regional Monitoring of Large Scale Aerosol Changes. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023702035] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The paper presents the preliminary results of the lidar&radiometer measurement campaign (LRMC-2017), estimation of statistical relations between aerosol mode concentrations retrieved from CALIOP and ground-based lidar stations and case study of fire smoke events in the Eurasian regions using combined ground-based and space lidar and radiometer observations.
Collapse
|
8
|
Fujikawa M, Kudo R, Nishizawa T, Oikawa E, Higurashi A, Okamoto H. Long-Term Analyses of Aerosol Optical Thickness Using Caliop. EPJ Web Conf 2020. [DOI: 10.1051/epjconf/202023702023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We developed an algorithm to derive extinction coefficients for four aerosol components (water-soluble, dust, sea salt, black carbon) from Cloud-Aerosol Lidar with Orthogonal Polarization (CALIOP) data. The algorithm was applied to the nine-year data for 2007–2015 and the results were compared to CALIOP standard product (CALIOP-ST) and MODerate resolution Imaging Spectroradiometer (MODIS) standard product (MODIS-ST). Comparisons of the total aerosol optical thickness (AOT) showed that MODIS-ST was the largest, followed by CALIOP-ST (Ver.4), and our product. CALIOP-ST (Ver.3) showed a similar magnitude to ours.
Collapse
|
9
|
Konishi S, Manaka D, Ikeda Y, Ota T, Kudo R, Ann H, Kawaguchi K, Sasaki N, Hamasu S, Nishitai R. Phase II study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at a dose of 130mg/m2 (nacG-SOX130) in clinical(c)Stage III gastric cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
10
|
Ann H, Manaka D, Konishi S, Ikeda Y, Ota T, Kudo R, Kawaguchi K, Sasaki N, Hamasu S, Nishitai R. Phase II study in progress to verify improved response with mFOLFOX6 after exposure to an immune checkpoint inhibitor in advanced gastric cancer. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.207] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
11
|
Kawaguchi K, Manaka D, Konishi S, Ikeda Y, Ota T, Kudo R, Sasaki N, Hamasu S, Nishitai R. Hepatic sinusoidal obstruction syndrome (HSOS) in cStage III gastric cancer patients undergoing neoadjuvant chemotherapy with oxaliplatin: a retrospective cohort study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.187] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
12
|
Manaka D, Konishi S, Kawaguchi K, Ikeda Y, Ota T, Kudo R, Ann H, Sasaki N, Hamasu S, Nishitai R. Prognostic implications of free cancer cells in gastric juice in gastric cancer patients who underwent surgery: a prospective cohort study. Ann Oncol 2019. [DOI: 10.1093/annonc/mdz155.102] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
13
|
Fushimi A, Kudo R, Takeyama H. Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response? Clin Breast Cancer 2019; 20:e82-e88. [PMID: 31255548 DOI: 10.1016/j.clbc.2019.05.015] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2019] [Revised: 05/12/2019] [Accepted: 05/29/2019] [Indexed: 10/26/2022]
Abstract
BACKGROUND Clinical response evaluation by image examination after neoadjuvant chemotherapy for breast cancer is important for determining drug response and progression. Mammography is less correlated with pathologic response assessment than magnetic resonance imaging or ultrasonography. The present study clarified characteristics of breast cancer patients with decreased microcalcifications after neoadjuvant chemotherapy to increase the accuracy of mammographic assessment. PATIENTS AND METHODS Consecutive patients who received neoadjuvant chemotherapy for breast cancer at our hospital from January 2013 to June 2017 were retrospectively reviewed. Characteristics of cases of microcalcifications before neoadjuvant chemotherapy and those showing a reduction after were examined. Stromal tumor-infiltrating lymphocytes were evaluated in the biopsy. Pathologic complete response was also explored in patients exhibiting a decrease in microcalcifications by neoadjuvant chemotherapy. RESULTS Seventy breast cancer cases were included; 37 had no malignant microcalcifications before neoadjuvant chemotherapy and 33 did. Breast cancer with microcalcifications was significantly more positive for human epidermal growth factor receptor 2 than those without microcalcifications (48% vs. 22%, P = .018). Only 6 of 33 patients with microcalcifications before neoadjuvant chemotherapy showed a decrease after treatment. These patients tended to have high stromal tumor-infiltrating lymphocytes (50% vs. 17%), segmental microcalcifications (66% vs. 33%), and pleomorphic/linear microcalcifications (83% vs. 37%). CONCLUSION These results suggest that neoadjuvant chemotherapy is able to decrease malignant calcifications, particularly segmental and pleomorphic/linear microcalcifications. By clarifying the mechanisms of formation and disappearance of microcalcifications, a consensus can be reached on whether microcalcifications apparent by mammography are useful for evaluating response to neoadjuvant chemotherapy.
Collapse
Affiliation(s)
- Atsushi Fushimi
- Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan.
| | - Rei Kudo
- Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| | - Hiroshi Takeyama
- Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| |
Collapse
|
14
|
Kasuda S, Kudo R, Yuui K, Sakurai Y, Hatake K. Induced Pluripotent Stem Cell-Derived Hematopoietic Embryoid Bodies Improve Mouse Status in Septic Peritonitis. Bull Exp Biol Med 2019; 166:667-670. [PMID: 30903503 DOI: 10.1007/s10517-019-04414-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2018] [Indexed: 10/27/2022]
Abstract
We examined the efficacy of embryoid bodies from 6-day induced pluripotent stem cells an in vivo sepsis model. Injection of embryoid bodies to septic mice improved the condition of their lungs and significantly increased their survival rate. Although embryoid bodies secretedsphingosine-1-phosphate in vitro, its serum levels in mouse plasma were significantly reduced compared to that in the control (untreated mice receiving PBS). Low concentrations of sphingosine-1-phosphate protected endothelial cells, while high concentrations disrupted endothelial barrier integrity. Therefore, exogenous sphingosine-1-phosphate secreted by embryoid bodies during early stage of sepsis might down regulate endogenous production of sphingosine-1-phosphate. Inhibition of excessive sphingosine-1-phosphate release protects against endothelial injury and suppresses a vicious cycle of inflammatory reactions. The obtained results open new prospects in induced pluripotent stem cells-based therapy for sepsis.
Collapse
Affiliation(s)
- S Kasuda
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan.
| | - R Kudo
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - K Yuui
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - Y Sakurai
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - K Hatake
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| |
Collapse
|
15
|
Fushimi A, Kinoshita S, Kudo R, Takeyama H. Incidental discovery of follicular lymphoma by sentinel lymph node biopsy and skin-sparing mastectomy for Paget's disease associated with invasive breast cancer. J Surg Case Rep 2019; 2019:rjz008. [PMID: 30697416 PMCID: PMC6344924 DOI: 10.1093/jscr/rjz008] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2018] [Revised: 12/31/2018] [Accepted: 01/07/2019] [Indexed: 11/13/2022] Open
Abstract
In breast cancer surgery, establishing a diagnosis other than lymph node metastasis of breast cancer, when performing a sentinel node biopsy in individuals with breast cancer, is rare. Here, we report a case of incidental discovery of follicular lymphoma by sentinel lymph node biopsy for Paget's disease associated with invasive breast cancer. A 60-year-old female initially presented with erosion on her left nipple and was clinically diagnosed with stage IA human epidermal growth factor receptor type 2 (HER2)-positive breast cancer and Paget's disease. Accordingly, skin-sparing mastectomy, sentinel lymph node biopsy, and immediate breast reconstruction were performed. Although an intraoperative pathological examination of frozen sections of lymph nodes presented no evidence of metastasis, it revealed large follicles. Based on immunohistochemistry of the additional lymph nodes, she was diagnosed with follicular lymphoma. Therefore, we initiated chemotherapy for follicular lymphoma followed by trastuzumab. At present, 6 years after the operation for breast cancer, the patient is doing well.
Collapse
Affiliation(s)
- Atsushi Fushimi
- Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan.,Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| | - Satoki Kinoshita
- Department of Surgery, The Jikei University Kashiwa Hospital, Chiba, Japan.,Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| | - Rei Kudo
- Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| | - Hiroshi Takeyama
- Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| |
Collapse
|
16
|
Abstract
Background: There is no decrease in the number of breast cancer deaths if screening mammography is performed
in women aged <40 years. However, NCCN guidelines recommend screening mammography in young women at risk of
hereditary breast cancer. Therefore, more accurate screening mammography for young women is needed. Objective: To
evaluate the features of screening mammographic findings, particularly microcalcifications, in women aged <50 years
to increase the positive predictive value of screening mammography in young women. Methods: We retrospectively
reviewed the data of consecutive women who underwent opportunistic and organized breast cancer screening at the
Sakuragaoka Hospital (Shizuoka, Japan) between April 2013 and March 2015. We compared the mammographic
findings and features of microcalcifications between women aged <40 and 40–49 years and those aged 50–74 years.
Results: The study included 3645 women. Of these 3645 women, 415 (11.4%) were aged <40 years, 1219 (33.4%)
were aged 40–49 years, and 2011 (55.2%) were aged 50–74 years. Women aged <50 years were more likely to be
recalled for microcalcifications than those aged 50–74 years (<40 years, 4.8%; 40–49 years, 4.3%; 50–74 years, 3.3%).
Young women were more likely to be recalled for small round and segmental microcalcifications [<40 years, odds ratio
(OR): 1.799 (95% CI: 0.751–2.846); 40–49 years, OR: 1.394 (95% CI: 0.714–2.074)] and less likely to be recalled for
small round and grouped microcalcifications [<40 years, OR: 0.603 (95% CI: 0.181–1.025); 40–49 years, OR: 0.961
(95% CI: 0.496–1.428)] compared with women aged 50–74 years. Conclusions: On screening mammography, women
aged <50 years had a higher tendency to be recalled for microcalcifications, particularly small round and segmental
microcalcifications. False-positive results may be reduced by reflecting the characteristics of microcalcification findings
among young women without breast cancer in the future.
Collapse
Affiliation(s)
- Atsushi Fushimi
- Department of Surgery, Sakuragaoka Hospital, Shizuoka, Japan.,Department of Surgery, The Jikei University School of Medicine, Tokyo, Japan
| | | | | | | | | |
Collapse
|
17
|
Kudo R. Is right-sided (sRt) BRAF mutated (mBRAF) metastatic colorectal cancer (mCRC) unresponsive to the 1st-line antiEGFR antibody treatment? Ann Oncol 2018. [DOI: 10.1093/annonc/mdy431.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Manaka D, Nishitai R, Konishi S, Ota T, Nishikawa Y, Kudo R, Kawaguchi K, An H, Hamasu S. Analysis of clinical outcomes of two antiEGFR antibodies, cetuximab and panitumumab, in the 1st line chemotherapy of RAS wild metastatic colorectal cancer, by neutrophil-to-lymphocyte ratio (NLR) kinetics. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.223] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Konishi S, Manaka D, An H, Nishikawa Y, Ota T, Kudo R, Kawaguchi K, Hamasu S, Nishitai R. Early outcomes of a pilot study of neoadjuvant chemotherapy with S-1 plus oxaliplatin at dose of 130mg/m2 (nacG-SOX130) in stage III gastric cancer. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
20
|
Kawaguchi K, Nishitai R, Manaka D, Ota T, Nishikawa Y, Kudo R, An H, Hamasu S, Konishi S. A phase II study of dose-escalation of regorafenib for patients with previously treated metastatic colorectal cancer – DEREGULATE study - Trial in progress. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy151.291] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
21
|
Nishizawa T, Sugimoto N, Shimizu A, Uno I, Hara Y, Kudo R. Aerosol observation using multi-wavelength Mie-Raman lidars of the Ad-Net and aerosol component analysis. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201817609005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
We deployed multi-wavelength Mie-Raman lidars (MMRL) at three sites of the AD-Net and have conducted continuous measurements using them since 2013. To analyze the MMRL data and better understand the externally mixing state of main aerosol components (e.g., dust, sea-salt, and black carbon) in the atmosphere, we developed an integrated package of aerosol component retrieval algorithms, which have already been developed or are being developed, to estimate vertical profiles of the aerosol components. This package applies to the other ground-based lidar network data (e.g., EARLINET) and satellite-borne lidar data (e.g., CALIOP/CALIPSO and ATLID/EarthCARE) as well as the other lidar data of the AD-Net.
Collapse
|
22
|
Kudo R, Nishizawa T, Higurashi A, Oikawa E. Remote sensing of aerosols by synergy of caliop and modis. EPJ Web Conf 2018. [DOI: 10.1051/epjconf/201817608012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
For the monitoring of the global 3-D distribution of aerosol components, we developed the method to retrieve the vertical profiles of water-soluble, light absorbing carbonaceous, dust, and sea salt particles by the synergy of CALIOP and MODIS data. The aerosol product from the synergistic method is expected to be better than the individual products of CALIOP and MODIS. We applied the method to the biomass-burning event in Africa and the dust event in West Asia. The reasonable results were obtained; the much amount of the water-soluble and light absorbing carbonaceous particles were estimated in the biomass-burning event, and the dust particles were estimated in the dust event.
Collapse
|
23
|
Manaka D, Nishitai R, Konishi S, Ohta T, Hattori T, Ann H, Kawaguchi K, Nishikawa Y, Kudo R, Hamasu S. Phase II study of Ccr-based dose-control of S-1 in the first-line chemotherapy of S-1/oxaliplatin (SOX) + bevacizumab regimen for advanced colorectal cancer. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx393.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
24
|
Maruyama H, Ujiie T, Takai J, Takahama Y, Sakagami H, Shibayama M, Fukumoto M, Ninomiya K, Hyang Ah P, Feng X, Takatsuji C, Hirose M, Kudo R, Shima Y, Nakayama R, Hamaie N, Zhang F, Moriizumi S. Cultural Difference in Conflict Management Strategies of Children and Its Development: Comparing 3- and 5-Year-Olds Across China, Japan, and Korea. Early Educ Dev 2015; 26:1210-1233. [PMID: 26430351 PMCID: PMC4566905 DOI: 10.1080/10409289.2015.1036344] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Research Findings: The purpose of this study was to examine differences in the development of conflict management strategies, focusing on 3- and 5-year-olds, through a comparison of 3 neighboring Asian cultures, those of China (n = 114), Japan (n = 98), and Korea (n = 90). The dual concern model of conflict management was adopted to probe which strategy children would prefer to use in 2 hypothetical conflict situations. Results indicated that, first, for disagreement, 3-year-olds in the 3 countries equally preferred the dominating strategy. For competition for resources, 3-year-olds differed in their strategy preference across all cultures. Second, the observed strategy preference of 3- to 5-year-old children in this study was more or less different from that of older schoolchildren, regardless of culture. Practice or Policy: These findings suggest the significance of the context, the complexity of the phenomenon of the development of cultural differences, and the significance of cohort sampling.
Collapse
Affiliation(s)
| | - Tatsuo Ujiie
- Department of Psychology and Human Developmental Sciences, Nagoya University
| | - Jiro Takai
- Department of Psychology and Human Developmental Sciences, Nagoya University
| | - Yuko Takahama
- Graduate School of Humanities and Science, Ochanomizu University
| | - Hiroko Sakagami
- Education, Psychology and Human Studies, Aoyama Gakuin University
| | | | | | | | | | | | | | - Miwa Hirose
- Faculty of Social Work Studies, Josai International University
| | - Rei Kudo
- Public Consulting Division, Value Management Institute. Inc.
| | | | | | - Noriko Hamaie
- Department of Psychology and Human Developmental Sciences, Nagoya University
| | - Feng Zhang
- School of Education, The Open University of China
| | | |
Collapse
|
25
|
Yuui K, Kudo R, Kasuda S, Hatake K. Ethanol attenuates vasorelaxation via inhibition of inducible nitric oxide synthase in rat artery exposed to interleukin-1β. Hum Exp Toxicol 2015; 35:938-45. [PMID: 26500219 DOI: 10.1177/0960327115611944] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
Abstract
Nitric oxide produced by inducible nitric oxide synthase (iNOS) regulates sepsis-induced hypotension. During septic shock, interleukin (IL)-1β is synthesized in endothelial cells and smooth muscle cells by endotoxin. Ethanol (EtOH) suppresses endotoxin-induced hypotension. The present study aimed to elucidate the effect of EtOH on gradual relaxation and iNOS expression induced by IL-1β in isolated rat superior mesenteric arteries (SMAs). Exposure to IL-1β-induced contraction in SMA rings, followed by a gradual relaxation of phenylephrine precontracted tone. Contraction was abolished by indomethacin (IM), cycloheximide (Chx), and endothelium denudation. In contrast, the gradual relaxation was abolished by NOS inhibitors, Chx, endothelium denudation, and inhibited by EtOH (50 and 100 mM). However, IM had no effect on relaxation. Western blot analysis demonstrated that iNOS expression was induced by IL-1β and was inhibited by EtOH and endothelium denudation. Furthermore, messenger RNA expression of iNOS, but not endothelial NOS, was inhibited by EtOH. These data suggest that IL-1β-induced contraction is mediated by thromboxane A2, whereas IL-1β-induced relaxation occurs via NO derived from iNOS. The endothelium plays an important role in vasorelaxation. Taken together, EtOH inhibits IL-1β-mediated vasorelaxation by suppressing endothelium iNOS expression. This study provides the first evidence of EtOH -induced inhibition of IL-1β-mediated vasorelaxation.
Collapse
Affiliation(s)
- K Yuui
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - R Kudo
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - S Kasuda
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| | - K Hatake
- Department of Legal Medicine, Nara Medical University, Kashihara, Nara, Japan
| |
Collapse
|
26
|
Kudo R, Okuda K, Usuki K, Nakano M, Yamamura K, Endo K. Three-dimensional surface figure measurement of high-accuracy spherical mirror with nanoprofiler using normal vector tracing method. Rev Sci Instrum 2014; 85:045101. [PMID: 24784653 DOI: 10.1063/1.4869473] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/03/2023]
Abstract
Processing technology using an extreme ultraviolet light source, e.g., next-generation lithography, requires next-generation high-accuracy mirrors. As it will be difficult to attain the degree of precision required by next-generation high-accuracy mirrors such as aspherical mirrors through conventional processing methods, rapid progress in nanomeasurement technologies will be needed to produce such mirrors. Because the measuring methods used for the surface figure measurement of next-generation mirrors will require high precision, we have developed a novel nanoprofiler that can measure the figures of high-accuracy mirrors without the use of a reference surface. Because the accuracy of the proposed method is not limited by the accuracy of a reference surface, the measurement of free-form mirrors is expected to be realized. By using an algorithm to process normal vectors and their coordinate values at the measurement point obtained by a nanoprofiler, our measurement method can reconstruct three-dimensional shapes. First, we measured the surface of a concave spherical mirror with a 1000-mm radius of curvature using the proposed method, and the measurement repeatability is evaluated as 0.6 nm. Sub-nanometer repeatability is realized, and an increase in the repeatability would be expected by improving the dynamic stiffness of the nanoprofiler. The uncertainty of the measurement using the present apparatus is estimated to be approximately 10 nm by numerical simulation. Further, the uncertainty of a Fizeau interferometer is also approximately 10 nm. The results obtained using the proposed method are compared with those obtained using a Fizeau interferometer. The resulting profiles are consistent within the range of each uncertainty over the middle portions of the mirror.
Collapse
Affiliation(s)
- R Kudo
- Research Center for Ultra-Precision Science and Technology, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - K Okuda
- Department of Precision Science and Technology, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - K Usuki
- Department of Precision Science and Technology, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - M Nakano
- Department of Precision Science and Technology, Graduate School of Engineering, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - K Yamamura
- Research Center for Ultra-Precision Science and Technology, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| | - K Endo
- Research Center for Ultra-Precision Science and Technology, Osaka University, 2-1 Yamada-oka, Suita, Osaka 565-0871, Japan
| |
Collapse
|
27
|
|
28
|
|
29
|
Kudo R, Uchiyama A, Yamazaki A, Sakami T, Ijima O. Decadal changes in aerosol optical thickness and single scattering albedo estimated from ground-based broadband radiometers: A case study in Japan. ACTA ACUST UNITED AC 2011. [DOI: 10.1029/2010jd014911] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
30
|
Yamamoto H, Nishikawa S, Yamazaki K, Kudo R. Efficacy of haptoglobin administration in the early postoperative course of patients with a diagnosis of HELLP syndrome. J OBSTET GYNAECOL 2009; 20:610-1. [PMID: 15512676 DOI: 10.1080/01443610020001459] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Affiliation(s)
- H Yamamoto
- Department of Obstetrics and Gynaecology, Sapporo Medical University, School of Medicine, Japan
| | | | | | | |
Collapse
|
31
|
Kudo R, Uchiyama A, Yamazaki A, Kobayashi E, Nishizawa T. Retrieval of aerosol single-scattering properties from diffuse and direct irradiances: Numerical studies. ACTA ACUST UNITED AC 2008. [DOI: 10.1029/2007jd009239] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
32
|
Hasan KN, Shoji M, Sugimoto K, Tsutaya S, Matsuda E, Kudo R, Nakaji S, Suda T, Yasujima M. Association of novel promoter single nucleotide polymorphisms in vasopressin V1a receptor gene with essential hypertension in nonobese Japanese. J Hum Hypertens 2007; 21:825-7. [PMID: 17653244 DOI: 10.1038/sj.jhh.1002227] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
We studied the association between four novel single nucleotide polymorphisms (SNPs) in the promoter region of V1aR gene and essential hypertension in 620 Japanese subjects (365 hypertensives and 255 healthy). A significant association was found between one of the genotypes and alleles at SNP -6951 and hypertension in a subsample of nonobese individuals. This association demonstrated an independent risk for nonobese hypertension.
Collapse
|
33
|
Nakamura O, Kudo R, Aoki H, Watanabe T. IgM secretion and absorption in the materno-fetal interface of a viviparous teleost, Neoditrema ransonneti (Perciformes; Embiotocidae). Dev Comp Immunol 2006; 30:493-502. [PMID: 16153706 DOI: 10.1016/j.dci.2005.06.024] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/27/2005] [Accepted: 06/26/2005] [Indexed: 05/04/2023]
Abstract
We investigated maternal IgM secretion in the ovary and the absorption of IgM by fetuses in a viviparous fish, Neoditrema ransonneti (Embiotocidae). Serum IgM, whose molecular weight was approx. 820k, was purified by two steps of gel filtration chromatography. Immunohistochemistry and Western blotting revealed that IgM was secreted from the epithelia of the ovigerous lamellae of pregnant females into ovarian cavity fluid. The IgM-secreting activity of ovigerous folds showed notable changes according to the reproductive stage. In fetuses, IgM was absorbed as macromolecules by enterocytes of the hypertrophied hindgut. IgM in the fetal blood was also demonstrated, although its concentration remained low during gestation. These findings suggest that IgM was transported from the maternal tissues to embryos via a unique pathway in N. ransonneti.
Collapse
Affiliation(s)
- O Nakamura
- School of Fisheries Sciences, Kitasato University, Ofunato, Iwate, 022-0101, Japan.
| | | | | | | |
Collapse
|
34
|
Yamazaki K, Endo T, Kitajima Y, Manase K, Nagasawa K, Honnma H, Hayashi T, Kudo R, Saito T. Elevation of both cyclooxygenase-2 and prostaglandin E2 receptor EP3 expressions in rat placenta after uterine artery ischemia-reperfusion. Placenta 2005; 27:395-401. [PMID: 15990166 DOI: 10.1016/j.placenta.2005.04.007] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/23/2005] [Revised: 04/22/2005] [Accepted: 04/22/2005] [Indexed: 11/25/2022]
Abstract
Intrauterine growth restriction (IUGR) has a multifactorial pathogenesis and is an important cause of perinatal mortality. The relationship between fetal weight and placental blood flow in an animal model of IUGR has been investigated, showing that fetal growth is regulated by placental blood flow. The aim of the present study was to determine whether ischemia-reperfusion (I/R) injury stimulates the prostaglandin E2 (PGE2) system or the vascular endothelial growth factor (VEGF) system in the placenta of a rat IUGR model. COX-2 is reported to be involved in ischemic damage in many organs. There are 4 types of PGE2 receptor (EP1, EP2, EP3 and EP4). It is well known that EP1 and EP3 is associated with vasoconstriction. In the present study, vessels were occluded in the right uterine horn on day 17 of pregnancy in rats, and the clamps were removed after 30 min of ischemia. At 24h, 48 h, and 5 days after I/R injury, the live fetuses and placentas were obtained by cesarean section. This study revealed that I/R injury caused IUGR 5 days after the treatment. COX-2 expression and EP3 receptor expression were significantly elevated at 24h after I/R injury, but VEGF mRNA expression was not altered in the placenta from the ischemic horn compared with the non-ischemic horn. These results suggested that induction of the COX-2-EP3 system in the placenta may be one of the causes of IUGR induced by uterine ischemia, because the EP3 receptor and PGE2 are well known to mediate vasoconstriction in many organs.
Collapse
Affiliation(s)
- K Yamazaki
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, South 1 West 16 Sapporo 060-8543, Japan
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Sagae S, Udagawa Y, Susumu N, Niwa K, Kudo R, Nozawa S. JGOG2033: Randomized phase III trial of whole pelvic radiotherapy vs cisplatin-based chemotherapy in patients with intermediate risk endometrial carcinoma. J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.5002] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. Sagae
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| | - Y. Udagawa
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| | - N. Susumu
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| | - K. Niwa
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| | - R. Kudo
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| | - S. Nozawa
- Sapporo Medcl Univ Sch of Medicine, Sapporo, Japan; Fujita Health Univ Sch of Medicine, Toyoake, Aichi, Japan; Keio Univ Sch of Medicine, Tokyo, Japan; Gifu Univ Sch of Medicine, Gifu, Japan
| |
Collapse
|
36
|
Saito T, Takehara M, Lee R, Fujimoto T, Nishimura M, Tanaka R, Ito E, Adachi K, Kudo R. Neoadjuvant chemotherapy with cisplatin, aclacinomycin A, and mitomycin C for cervical adenocarcinoma - a preliminary study. Int J Gynecol Cancer 2004; 14:483-90. [PMID: 15228422 DOI: 10.1111/j.1048-891x.2004.014309.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Between 1989 and 2002, 28 patients with locally advanced cervical adenocarcinoma (bulky IB-IIIB) were recruited for a pilot study aimed at evaluation of the effectiveness of neoadjuvant chemotherapy with cisplatin, aclacinomycin-A, and mitomycin-C (PAM), followed by radical surgery. This regimen was administrated intra-arterially or intravenously. In addition to patients treated with PAM, we retrospectively analyzed the prognoses of 26 patients in stage I and II, who had been treated between 1975 and 1981 with radical surgery with/without radiation therapy. Twenty-eight patients received PAM therapy as neoadjuvant chemotherapy, and 75.0% of the 16 intra-arterially infused patients showed a response, as did 66.7% of the 12 intravenously infused patients. There was a significant difference in the 5-year prognosis of stage II (PAM group, 72.9%; without-PAM group, 36.4%). The results suggest that, as the free space in the parametrium is widened by neoadjuvant chemotherapy with PAM, it is possible that the tumor could be completely resected by radical hysterectomy. Thus, neoadjuvant chemotherapy with PAM is expected to improve the survival rate of patients with advanced cervical adenocarcinoma by the preliminary study. However, the survival rates of stage II with lymph node metastasis in the without-PAM group seem low, and we must also consider that the various technologies to evaluate and treat the cervical adenocarcinomas, e.g. computed tomography, magnetic resonance imaging, and surgical equipments, had improved during 1989-2002 than was the scenario during 1975-1981, and these improvements contributed to better prognosis. A prospective-randomized study is needed to assess the value of this approach compared with standard management.
Collapse
Affiliation(s)
- T Saito
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Chuo-ku, Sapporo, Japan.
| | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Takehara M, Saito T, Mizumoto H, Baba T, Tanaka R, Fujimoto T, Adachi K, Kudo R. Imaging studies in patients with malignant melanoma in the female genital tract. Int J Gynecol Cancer 2002; 12:506-9. [PMID: 12366671 DOI: 10.1046/j.1525-1438.2002.01145.x] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
The purpose of this study was to review magnetic resonance imaging (MRI) and pathologic features of primary malignant melanoma (melanoma) in the female genital tract. We retrospectively evaluated MRI in six women with melanoma of the genital tract. The signal intensity of the tumor on T1-weighted images (WI) was compared with the amount of melanin granules in hematoxylin-eosin stained sections of resected specimen. On T1WI, four melanomas showed a high signal intensity, one intermediate, and one low. The four melanomas with a high signal intensity on T1W1 were rich in melanin granules, while the one intermediate tumor had few granules. The other one was amelanotic. We believe that a high signal on T1WI is characteristic of primary melanotic melanoma of the female genital tract. Our findings suggest that it is strongly influenced by the presence of melanin granules.
Collapse
Affiliation(s)
- M Takehara
- Department of Obstetrics and Gynecology, Sapporo Medical University, Sapporo, Japan
| | | | | | | | | | | | | | | |
Collapse
|
38
|
Takehara M, Saito T, Mizumoto H, Baba T, Tanaka R, Fujimoto T, Adachi K, Kudo R. Imaging studies in patients with malignant melanoma in the female genital tract. Int J Gynecol Cancer 2002. [DOI: 10.1136/ijgc-00009577-200209000-00017] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
The purpose of this study was to review magnetic resonance imaging (MRI) and pathologic features of primary malignant melanoma (melanoma) in the female genital tract. We retrospectively evaluated MRI in six women with melanoma of the genital tract. The signal intensity of the tumor on T1-weighted images (WI) was compared with the amount of melanin granules in hematoxylin-eosin stained sections of resected specimen.On T1WI, four melanomas showed a high signal intensity, one intermediate, and one low. The four melanomas with a high signal intensity on T1W1 were rich in melanin granules, while the one intermediate tumor had few granules. The other one was amelanotic. We believe that a high signal on T1WI is characteristic of primary melanotic melanoma of the female genital tract. Our findings suggest that it is strongly influenced by the presence of melanin granules.
Collapse
|
39
|
Abstract
We experienced a case of hemorrhagic infarction of the ovarian fibroma and that indicated the characteristic following appearance: exhibiting a high signal intensity area observed at the periphery of mass on T1-weighted MRI (magnetic resonance imaging). It was thought that this appearance developed because hemorrhagic infarction was caused by subacute ovarian torsion. This is a useful finding for suspecting hemorrhagic infarction preoperatively.
Collapse
Affiliation(s)
- M Takehara
- Department of Obstetrics and Gynecology, Sapporo Medical University, Japan
| | | | | | | | | | | |
Collapse
|
40
|
Abstract
We reported previously that 7-hydroperoxycholesterols, 7 alpha- and 7 beta-hydroperoxycholest-5-en-3 beta-ol (7 alpha-OOH and 7 beta-OOH), indicated lipid peroxidation. In the present study, we measured not only 7-hydroperoxycholesterols but also oxysterols (7 alpha- and 7 beta-hydroxycholesterol, 7 alpha-OH, and 7 beta-OH) and 3 beta-hydroxycholest-5-en-7-one (7-keto) in the brains of rats that underwent either a sham operation (control), hypoxia, or CO inhalation (1005 ppm) at 37 degrees C for 90 min followed by 48 h of recovery. The levels of 7-hydroperoxycholesterols, 7 beta-OH, and 7-keto were low in the hypoxia group, while the levels were unaltered in the CO group compared with the controls. Among the three groups of CO inhalation, these levels were high in the hyperthermia group (39 degrees C), and the 7-hydroperoxycholesterols were low in the hypothermia group (32 degrees C), compared with the control group. The blood O(2) saturation was almost normal in the hypothermia group, while it was similarly low in the hyperthermia and normothermia groups. The temperature-dependent lipid peroxidation in the brain after CO inhalation and recovery can not be explained by hypoxia due to CO-hemoglobin formation, but may contribute to the delayed neuronal death following CO inhalation. Hypothermia may be applicable to treat patients after CO inhalation.
Collapse
Affiliation(s)
- R Kudo
- Department of Legal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan
| | | | | | | | | | | |
Collapse
|
41
|
Ishioka S, Sagae S, Sugimura M, Nishioka Y, Kobayashi K, Kudo R. Clinical factors and biomarkers which affect a new universal grading system for ovarian epithelial carcinoma. J Obstet Gynaecol Res 2001; 27:313-8. [PMID: 11794816 DOI: 10.1111/j.1447-0756.2001.tb01278.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
Abstract
OBJECTIVE To detect clinical factors and biomarkers which affect a new grading system for ovarian epithelial cancer that was proposed by Shimizu et al. and to analyze the impact of those factors on malignant behaviors of the tumor. METHODS Review and scoring of specimens of paraffin embedded tissues of epithelial ovarian cancer were carried out according to the new universal grading system in 110 women who underwent initial treatments including the primary operation in our university hospital between January 1990 and June 1999. As biomarkers, expression of Bcl-2, Bax, Bcl-X, and the accumulation of P53 protein were also studied immunohistochemically. RESULTS This grading system functioned as a prognostic indicator. Five-year survivals of the patients was 77.6, 36.3, and 17.4%, for Grade 1, Grade 2, and Grade 3, respectively. The grade was also correlated with clinical stages, histologic subtypes, operative completeness, para-aortic lymph nodes metastasis, and the expression of Bax protein, with univariate analysis. Multivariate analysis revealed histological subtypes and para-aortic lymph nodes metastasis to be important factors which affected the grading system. CONCLUSION These results demonstrate that the new universal grading system is useful, and that this grading system might reflect potential of metastasis or dissemination of the ovarian cancer.
Collapse
Affiliation(s)
- S Ishioka
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Hokkaido, Japan
| | | | | | | | | | | |
Collapse
|
42
|
Adachi J, Kudo R, Ueno Y, Hunter R, Rajendram R, Want E, Preedy VR. Heart 7-hydroperoxycholesterol and oxysterols are elevated in chronically ethanol-fed rats. J Nutr 2001; 131:2916-20. [PMID: 11694618 DOI: 10.1093/jn/131.11.2916] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Recently, cholesterol hydroperoxides have been shown to be sensitive pathogenic markers of reactive oxygen species (ROS)-mediated damage though they have never been measured in heart tissue. We hypothesized that cholesterol hydroperoxides and oxysterols, putative cardiotoxic products of cholesterol oxidation, are elevated in the hearts of alcoholics as a consequence of ROS-mediated reactions. To test this, we measured 7alpha- and 7beta-hydroperoxycholest-5-en-3beta-ol (7alpha-OOH and 7beta-OOH) by HPLC with postcolumn chemiluminescence as well as 7alpha- and 7beta-hydroxycholesterol (7alpha-OH and 7beta-OH) and 3beta-hydroxycholest-5-en-7-one (also termed 7-ketocholesterol; 7-keto) by HPLC-UV in cardiac muscle of alcohol-fed rats. Alcohol feeding was carried out using a pair-feeding protocol with 35% of total dietary energy as ethanol; controls were pair-fed isocaloric glucose. After 6-7 wk treatment with alcohol, heart 7alpha-OOH, 7beta-OOH and 7beta-OH were significantly greater than in controls. Levels of heart phospholipid 16:0 and 18:1 were lower than in controls, while 18:0 and 18:2 were greater. This is the first report of the presence of 7alpha-OOH, 7beta-OOH and 7alpha-OH in cardiac tissue. The elevations in 7alpha-OOH and 7beta-OOH as well as 7beta-OH are evidence of increased oxidative stress and possible membrane changes. Alterations in the proportions of 16:0, 18:1, 18:2 and 18:0 in heart phospholipids provide further evidence of an altered membrane domain.
Collapse
Affiliation(s)
- J Adachi
- Department of Legal Medicine, Kobe University Graduate School of Medicine, Japan.
| | | | | | | | | | | | | |
Collapse
|
43
|
Takai S, Murata N, Kudo R, Narematsu N, Kakuda T, Sasaki Y, Tsubaki S. Two new variants of the Rhodococcus equi virulence plasmid, 90 kb type III and type IV, recovered from a foal in Japan. Vet Microbiol 2001; 82:373-81. [PMID: 11506930 DOI: 10.1016/s0378-1135(01)00398-4] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
Abstract
This report describes the discovery of two new virulence plasmid types from a crossbred foal with Rhodococcus equi pneumonia in Kumamoto died with severe R. equi pneumonia and ulcerative enteritis. R. equi was isolated in large numbers and isolates from the foal were investigated for the presence of virulence-associated 15-17 kDa antigens (VapA) by colony blotting, using the monoclonal antibody 10G5, and by gene coding for VapA by PCR. Plasmid DNAs extracted from the isolates were digested with restriction endonucleases BamHI, EcoRI, EcoT22I, and HindIII. The digestion patterns that resulted divided the plasmids of these isolates into two closely related types. The digestion patterns were then compared with eight representative virulence plasmid types (85 kb types I, II, III and IV, 87 kb types I and II, 90 kb types I and II), which have already been reported. None of the EcoRI and EcoT22I digestion patterns of the eight representative plasmids matched those of the two plasmid types. We tentatively designated these new plasmid types as 90 kb type III and type IV, since HindIII and BamHI digestion patterns of the two plasmid types were identical with those of a 90 kb type I plasmid. This study, demonstrated that there are at least 10 distinct but closely related plasmids present in isolates from horses in the world.
Collapse
Affiliation(s)
- S Takai
- Department of Animal Hygiene, School of Veterinary Medicine and Animal Sciences, Kitasato University, Towada, 034-8628, Aomori, Japan.
| | | | | | | | | | | | | |
Collapse
|
44
|
Endo T, Kitajima Y, Nishikawa A, Manase K, Shibuya M, Kudo R. Cyclic changes in expression of mRNA of vascular endothelial growth factor, its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea. Fertil Steril 2001; 76:762-8. [PMID: 11591411 DOI: 10.1016/s0015-0282(01)02012-x] [Citation(s) in RCA: 20] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
OBJECTIVE To evaluate the expression of mRNA of vascular endothelial growth factor (VEGF), its receptors Flt-1 and KDR/Flk-1, and Ets-1 in human corpora lutea. DESIGN Prospective laboratory study. SETTING University hospital in Japan. PATIENT(S) Women with regular menstrual cycles who underwent hysterectomy. INTERVENTION(S) Fifteen corpora lutea were obtained during hysterectomy (5 in the early luteal phase, 5 in the mid-luteal phase, and 5 in the late luteal phase). MAIN OUTCOME MEASURE(S) Expression of VEGF, Flt-1, KDR/Flk-1, and Ets-1 in human corpora lutea on northern blot analysis or immunohistochemistry. RESULT(S) Human corpora lutea in early luteal phase and mid-luteal phase had high VEGF mRNA expression. Expression of VEGF mRNA was significantly reduced in the late luteal phase. Immunohistochemistry showed that VEGF protein was expressed mainly in granulosa lutein cells and faintly in thecal lutein cells. Staining of VEGF protein was decreased in human corpora lutea in the late luteal phase. Expression of Flt-1 and KDR/Flk-1 mRNA was increased in the early luteal phase and mid-luteal phase and decreased in the late luteal phase. Immunohistochemistry showed that Flt-1 and KDR/Flk-1 proteins were expressed mainly in granulosa lutein cells and faintly in thecal lutein cells and endothelial cells in the early luteal phase and mid-luteal phase; their protein staining was reduced in the late luteal phase. Expression of Ets-1 mRNA changed similarly to VEGF and its receptor mRNA in human corpora lutea during the luteal phase. CONCLUSION(S) Levels of mRNA of VEGF and its receptors Flt-1 and KDR/Flk-1 in human luteal cells may be related to luteal function.
Collapse
Affiliation(s)
- T Endo
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan.
| | | | | | | | | | | |
Collapse
|
45
|
Affiliation(s)
- N Akutagawa
- Department of Obstetrics and Gynaecology, Sapporo Medical University, Hokkaido, Japan
| | | | | | | | | |
Collapse
|
46
|
Abstract
To examine whether and at which stage of endometrial carcinogenesis decreased connexin expression occurs, we investigated changes in the expression of the gap junction proteins, connexin 26 (Cx26), Cx32 and Cx43, in human endometrial hyperplasia and cancer samples. Forty-eight endometrial tissue samples (15 endometrial hyperplasias and 33 endometrial cancers) were subjected to immunofluorescence and RT-PCR analysis. In endometrial hyperplasia, Cx26 was aberrantly expressed in all samples as revealed immunohistochemically. There was weak or negative expression in 12 samples (80.0%) and diffuse expression in cytoplasm in 3 samples (20.0%). Cx32 expression in those samples was similar to that of Cx26; there was weak or negative expression in 11 samples (73.3%) and diffuse expression in 4 samples (26.7%). In endometrial cancer, Cx26 was expressed weakly or negatively in 25 samples (75.8%), diffusely in 6 samples (18.2%) and normally in 2 samples (6.1%), while Cx32 was expressed weakly or negatively in 26 samples (78.8%), diffusely in 5 samples (15.2%) and normally in 2 samples (6.1%). It was confirmed that weak staining of Cx26 and Cx32 was due to poor expression of their mRNA. All samples showed weak Cx43 protein expression as revealed by immunohistochemical analysis. In the majority of samples, concomitant expression levels of Cx26 and Cx32 protein were observed, confirming our long-term hypothesis that Cx26 and Cx32 are both abnormally regulated in a coordinated fashion in the endometrium. Our results indicate that during endometrial carcinogenesis, loss of gap junctional intercellular communication (GJIC) may occur due to the suppressed expression and the aberrant localization of connexin at relatively early stages.
Collapse
Affiliation(s)
- T Saito
- Department of Obstetrics and Gynecology, Sapporo Medical University, Sapporo, Japan.
| | | | | | | |
Collapse
|
47
|
Ishioka S, Sagae S, Kudo R. [Feasibility, activity, and change in the level of blood paclitaxel concentration after weekly paclitaxel therapy for a patient with recurrent ovarian cancer]. Gan To Kagaku Ryoho 2001; 28:1017-21. [PMID: 11478132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/20/2023]
Abstract
The patient was a 59-year-old woman with recurrent ovarian cancer. A CT scan of the abdomen showed enlargement of abdominal para-aortic lymph nodes (PAN) after the primary operation and 8 cycles of the combination chemotherapy with paclitaxel (TXL) and carboplatinum (CBDCA). As a second line chemotherapy for the patient, weekly administration of TXL (60 mg/m2/week x 3 weeks) was given. The toxicity was acceptable and less pronounced than with the standard TXL + CBDCA therapy. Peak blood TXL concentration, about 90 ng/ml, was achieved 4 hours after the administration of TXL. The blood TXL concentration was below the detectable limit 48 h after the administration of TXL. An almost 50% shrinkage in the size of the PAN was obtained after 2 cycles of treatment. Good QOL is being maintained without any repeated aggravation of the tumor.
Collapse
Affiliation(s)
- S Ishioka
- Dept. of Obstetrics and Gynecology, Sapporo Medical University
| | | | | |
Collapse
|
48
|
Baba T, Koizumi M, Suzuki T, Yamanaka I, Yamashita S, Kudo R. Specific detection of circulating tumor cells by reverse transcriptase-polymerase chain reaction of a beta-casein-like protein, preferentially expressed in malignant neoplasms. Anticancer Res 2001; 21:2547-51. [PMID: 11724320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
Abstract
Beta-casein-like protein (BCLP) is a putative protein on cervical cancer and exhibits immunological characteristics similar to those of bovine beta-casein. We evaluated if BCLP mRNA detection in the blood is useful in gynecologic malignancies. We examined 30 patients with uterine cancer, nine cultured cancer cell lines and 26 healthy women volunteers. From these study populations and samples, total RNA was obtained. Reverse transcriptase-PCR (RT-PCR) of BCLP was performed on each sample. Eighteen (60.0%) patients and 4 (15.4%) volunteers were positive for BCLP mRNA. The RT-PCR reached sensitivity and specificity of 60.0% and 84.6%, respectively. Of eight patients having diagnosed recurrence, 7 (87.5%) were positive for BCLP mRNA. In patients with recurrence, sensitivity and specificity were 87.5% and 50%, respectively. The expression of mRNA showed a correlation with recurrence, but no correlation with metastasis or histological type. BCLP was specifically expressed in cancer cells and might be an aid in clinical diagnosis.
Collapse
MESH Headings
- Antigens, Neoplasm/biosynthesis
- Antigens, Neoplasm/genetics
- Caseins/biosynthesis
- Caseins/genetics
- Endometrial Neoplasms/blood
- Endometrial Neoplasms/genetics
- Endometrial Neoplasms/pathology
- Female
- Humans
- Lymphatic Metastasis
- Neoplasm Metastasis
- Neoplasm Recurrence, Local/blood
- Neoplasm Recurrence, Local/genetics
- Neoplasm Recurrence, Local/pathology
- Neoplastic Cells, Circulating/metabolism
- RNA, Messenger/biosynthesis
- RNA, Messenger/blood
- RNA, Neoplasm/metabolism
- Reverse Transcriptase Polymerase Chain Reaction
- Sensitivity and Specificity
- Tumor Cells, Cultured
- Uterine Cervical Neoplasms/blood
- Uterine Cervical Neoplasms/genetics
- Uterine Cervical Neoplasms/pathology
Collapse
Affiliation(s)
- T Baba
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, Sapporo, Japan.
| | | | | | | | | | | |
Collapse
|
49
|
Baba T, Koizumi M, Suzuki T, Yamanaka I, Yamashita S, Kudo R. Cloning and characterization of a tumor-associated antigen, beta-casein-like protein. Biochem Biophys Res Commun 2001; 284:340-5. [PMID: 11394883 DOI: 10.1006/bbrc.2001.4966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Monoclonal antibody (MAb) 1C5 reacts with 87% of uterine cervical adenocarcinoma and bovine beta -casein, but not with squamous cell carcinoma. To clarify the characteristics of the antigen (beta-casein-like protein; BCLP) recognized by MAb 1C5, molecular cloning was performed using 5' rapid amplification of the cDNA ends (5' RACE) and the oligo-capping method. The protein predicted from the cDNA consisting of 937 nucleotides comprises 222 amino acids. The BCLP gene and deduced amino acid sequences were novel and showed no similarity to known cancer-associated genes in the database. Northern blot analysis showed that a 1.1 kb transcript was ubiquitously expressed in cancer cell lines and was predominantly expressed in uterine cervical adenocarcinoma. To clarify the function of BCLP, BCLP cDNA was transfected into L929 cells, resulting in a significant increase in cell area, a downregulation of cell growth rate and a decrease in cell attachment. We conclude that BCLP might be associated with cell morphology and a regulation of growth pattern of tumor.
Collapse
MESH Headings
- Adenocarcinoma/metabolism
- Adenocarcinoma/pathology
- Amino Acid Sequence
- Antibodies, Monoclonal/metabolism
- Antigens, Neoplasm/genetics
- Antigens, Neoplasm/metabolism
- Antigens, Neoplasm/pharmacology
- Base Sequence
- Blotting, Northern
- Caseins/genetics
- Caseins/immunology
- Caseins/metabolism
- Cell Adhesion/drug effects
- Cell Division/drug effects
- Cell Size/drug effects
- Cloning, Molecular
- DNA, Complementary/genetics
- DNA, Complementary/isolation & purification
- DNA, Complementary/pharmacology
- Down-Regulation/drug effects
- Female
- Fibroblasts/cytology
- Fibroblasts/drug effects
- Fibroblasts/metabolism
- Humans
- Molecular Sequence Data
- RNA, Messenger/metabolism
- Transfection
- Tumor Cells, Cultured
- Uterine Cervical Neoplasms/metabolism
- Uterine Cervical Neoplasms/pathology
- Uterine Neoplasms/metabolism
- Uterine Neoplasms/pathology
Collapse
Affiliation(s)
- T Baba
- Department of Obstetrics and Gynecology, Sapporo Medical University, Sapporo, Japan.
| | | | | | | | | | | |
Collapse
|
50
|
Fukunaka K, Saito T, Wataba K, Ashihara K, Ito E, Kudo R. Changes in expression and subcellular localization of nuclear retinoic acid receptors in human endometrial epithelium during the menstrual cycle. Mol Hum Reprod 2001; 7:437-46. [PMID: 11331666 DOI: 10.1093/molehr/7.5.437] [Citation(s) in RCA: 39] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
The endometrium is a uniquely dynamic tissue in that it undergoes monthly cycles of proliferation and secretory activity, and is regulated by ovarian steroid hormones. In this study, we focused on retinoic acid receptors (RAR and RXR) which are ligand-dependent transcription factors belonging to the large family of steroid hormones and are expected to affect to cell growth and differentiation in the endometrium. We analysed the expression and subcellular localization of the RA receptors in 57 samples of human endometrium by immunohistochemistry and Western blotting. In the nuclei of the endometrial epithelium, the RA receptors were expressed strongly in the proliferative phase. However, RAR were drastically reduced in the epithelial nuclei during the secretory phase in association with changes in serum oestradiol and in the expression of the oestrogen receptor. The expression of RXR was localized in the epithelial nuclei throughout the menstrual cycle. Confocal laser scanning microscopical observation clearly showed the difference in the localization between RAR and RXR in the secretory phase. Furthermore the findings of immuno-electron microscopy showed pooled RAR around the rough endoplasmic reticulum, suggesting that transport of these receptors to the nuclei is inhibited. These findings suggest that RAR and RXR work mainly in the proliferative phase and that in the endometrium RXR may play a different role to RAR during the secretory phase.
Collapse
Affiliation(s)
- K Fukunaka
- Department of Obstetrics and Gynecology, Sapporo Medical University School of Medicine, South-1 West-16 Chuo-ku, Sapporo 060, Japan
| | | | | | | | | | | |
Collapse
|